Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03537885 · ClinicalTrials.gov registry record · NA
EEG Analytics to Determine Effectiveness of a tDCS Protocol
A NA study, sponsored by Burke Medical Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT03537885: Completed NA study, sponsored by Burke Medical Research Institute.
NCT03537885 is a NA study that has completed, run by Burke Medical Research Institute. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03537885, a NA study, has completed, sponsored by Burke Medical Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The goal of this study is to monitor the brain using electroencephalography (EEG) while transcranial direct current stimulation (tDCS) is being administered, as a potential pathway to determine neurophysiological markers capable of forecasting the intensity of a subject's response to tDCS.
Primary Outcome
A measure of the muscle's responsiveness to non-invasive stimulation.
Interventions
- DIAGNOSTIC_TEST Electroencephalography (EEG)
- DIAGNOSTIC_TEST Transcranial Magnetic Stimulation
- DIAGNOSTIC_TEST Transcranial Direct Current Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2015-02-01 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
What the finished NCT03537885 record still lists
NCT03537885 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Electroencephalography (EEG) is the first listed.
NCT03537885 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03537885 about?
NCT03537885 is a clinical study titled "EEG Analytics to Determine Effectiveness of a tDCS Protocol". The goal of this study is to monitor the brain using electroencephalography (EEG) while transcranial direct current stimulation (tDCS) is being administered, as a potential pathway to determine neurophysiological markers capable of forecasting the intensity of a subject's response to tDCS.
What is the current status of trial NCT03537885?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2015-02-01. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03537885?
The interventions under investigation include: Electroencephalography (EEG) (DIAGNOSTIC_TEST), Transcranial Magnetic Stimulation (DIAGNOSTIC_TEST), Transcranial Direct Current Stimulation (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03537885?
This trial is sponsored by Burke Medical Research Institute, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03537885's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI